Twist Bioscience (TWST) Change in Account Payables (2017 - 2026)

Twist Bioscience has reported Change in Account Payables over the past 10 years, most recently at $69000.0 for Q1 2026.

  • Quarterly Change in Account Payables fell 90.3% to $69000.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $4.5 million through Mar 2026, up 1201.46% year-over-year, with the annual reading at $9.3 million for FY2025, 179.05% up from the prior year.
  • Change in Account Payables was $69000.0 for Q1 2026 at Twist Bioscience, down from $1.5 million in the prior quarter.
  • Over five years, Change in Account Payables peaked at $6.9 million in Q3 2022 and troughed at -$7.5 million in Q1 2023.
  • The 5-year median for Change in Account Payables is $69000.0 (2026), against an average of $232235.3.
  • Year-over-year, Change in Account Payables skyrocketed 65740.0% in 2022 and then plummeted 889.83% in 2023.
  • A 5-year view of Change in Account Payables shows it stood at $3.3 million in 2022, then tumbled by 228.12% to -$4.2 million in 2023, then skyrocketed by 235.81% to $5.7 million in 2024, then plummeted by 74.23% to $1.5 million in 2025, then plummeted by 95.31% to $69000.0 in 2026.
  • Per Business Quant, the three most recent readings for TWST's Change in Account Payables are $69000.0 (Q1 2026), $1.5 million (Q4 2025), and -$284000.0 (Q3 2025).